This study investigates advanced solid tumors. It looks into how an investigational medication works when used alone or with other treatments.
The study evaluates the safety and side effects of the investigational medication. It also examines how well it treats advanced solid tumors.
- Who can participate: Adults with conditions like non-small cell lung cancer, head and neck cancer, or HER2-negative breast cancer may participate. Participants should have measurable disease and meet specific health criteria.
- Study details: Participants will receive an investigational medication. Some will also receive pembrolizumab or chemotherapy. A placebo might be used, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand